Rhodes & Robby Drugs Inc

Rhodes & Robby Drugs Inc ( RHODES & ROBBY DRUGS INC ) is An Pharmacist Provider in Pelahatchie, MS. The NPI Number for Rhodes & Robby Drugs Inc is 1275669517.

The current location address for Rhodes & Robby Drugs Inc is 114 BROOKS STREET Pelahatchie, MS 39145 and the contact number is 6018548252 and fax number is 6018546057. The mailing address for Rhodes & Robby Drugs Inc is PO BOX 249 114 BROOKS STREET Pelahatchie, MS 39145- 6018548252 (mailing address contact number - 6018548252).

An individual licensed by the appropriate state regulatory agency to engage in the practice of pharmacy. The practice of pharmacy includes, but is not limited to, assessment, interpretation, evaluation, and implementation, initiation, monitoring or modification of medication and or medical orders; the compounding or dispensing of medication and or medical orders; participation in drug and device procurement, storage, and selection; drug administration; drug regimen reviews; drug or drug-related research; provision of patient education and the provision of those acts or services necessary to provide medication therapy management services in all areas of patient care.

What is the NPI Number for Rhodes & Robby Drugs Inc ?

Answer: The NPI Number for Rhodes & Robby Drugs Inc is 1275669517

Where is Rhodes & Robby Drugs Inc located?

Answer: Rhodes & Robby Drugs Inc is located at 114 BROOKS STREET Pelahatchie, MS 39145.

What is the specialty for Rhodes & Robby Drugs Inc ?

Answer: The Specialty of Rhodes & Robby Drugs Inc is An Pharmacist Provider.

Are there any online reviews for Rhodes & Robby Drugs Inc ?

Answer: Not yet!

Are there any other health care providers in Pelahatchie, MS?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Rhodes & Robby Drugs Inc

Number of HCPCS	7
Number of Medicare Beneficiaries	36
Number of Services	76
Total Submitted Charge Amount	3044.33
Total Medicare Allowed Amount	3044.33
Total Medicare Payment Amount	3044.33
Total Medicare Standardized Payment Amount	3108.46
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services	5
Number of Medicare Beneficiaries With Drug Services	36
Number of Drug Services	38
Total Drug Submitted Charge Amount	2522.12
Total Drug Medicare Allowed Amount	2522.12
Total Drug Medicare Payment Amount	2522.12
Total Drug Medicare Standardized Payment Amount	2471.58
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services	2
Number of Medicare Beneficiaries With Medical	36
Number of Medical Services	38
Total Medical Submitted Charge Amount	522.21
Total Medical Medicare Allowed Amount	522.21
Total Medical Medicare Payment Amount	522.21
Total Medical Medicare Standardized Payment Amount	636.88
Average Age of Beneficiaries	75
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84	18
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	20
Number of Male Beneficiaries	16
Number of Non-Hispanic White Beneficiaries
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia
Percent (%) of Beneficiaries Identified With Asthma
Percent (%) of Beneficiaries Identified With Cancer
Percent (%) of Beneficiaries Identified With Heart Failure
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.31
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease
Percent (%) of Beneficiaries Identified With Depression
Percent (%) of Beneficiaries Identified With Diabetes
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.67
Percent (%) of Beneficiaries Identified With Hypertension	0.69
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.39
Percent (%) of Beneficiaries Identified With Osteoporosis
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.53
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke	0
Average HCC Risk Score of Beneficiaries	1.0306